Today's Daily Dose brings you news about FDA approval of AstraZeneca's CALQUENCE; delay in the release of GlycoMimetics' phase III trial of Uproleselan in AML and Onconova's agreement with Knight Therapeutics.
from RTT - Biotech https://ift.tt/34bUoIK
via IFTTT
No comments:
Post a Comment